Skip to main content

Advertisement

SpringerLink
Log in

Infective endocarditis

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Infective endocarditis remains a serious and potentially fatal disease. Even with appropriate therapy, mortality rates remain at about 10% to 20%. Common errors in treatment include starting antibiotics before obtaining at least three blood cultures, failing to use bactericidal drugs, stopping therapy too early, and delaying heart surgery when it is indicated. The epidemiology of endocarditis will continue to evolve, and we will see more cases that are hospital acquired, more cases associated with the presence of cardiac support devices, and cases associated with line-related bacteremia. Therefore, organisms associated with endocarditis will also likely evolve. We will see more cases due to multiresistant organisms (eg, vancomycin-resistant enterococci, glycopeptide-resistant staphylococci, and multidrug-resistant gram-negative rods) as well as yeast and fungi.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Durack DT, Lukes AS, Bright DK: New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994, 96:200–209.

    Article  PubMed  CAS  Google Scholar 

  2. Scheld WM, Sande MA: Endocarditis and intravascular infections. In Mandell, Douglas and Bennettt’s Principles and Practice of Infectious Diseases, edn 4. Edited by Mandell GL, Bennett JE, Dolin R. New York: Churchill Livingstone; 1995:740–783.

    Google Scholar 

  3. van der Meer JTM, Thompson J, Valkenburg HA, Michel MF: Epidemiology of bacterial endocarditis in the Netherlands. Arch Intern Med 1992, 152:1863–1868.

    Article  PubMed  Google Scholar 

  4. Fang G, Keys TF, Gentry LO, et al.: Prosthetic valve endocarditis resulting from nosocomial bacteria: a prospective, multicenter study. Ann Intern Med 1993, 119:560–567.

    PubMed  CAS  Google Scholar 

  5. Bayer AS, Bolger AF, Taubert KA, et al.: Diagnosis and management of infective endocarditis and its complications. Circulation 1998, 98:2936–2948.

    PubMed  CAS  Google Scholar 

  6. Daniel WG, Mügge A: Transesophageal echocardiography. N Engl J Med 1995, 332:1268–1279.

    Article  PubMed  CAS  Google Scholar 

  7. Hoesley CJ, Cobbs CG: Endocarditis at the millennium. J Infect Dis 1999, 179:S360-S365.

    PubMed  Google Scholar 

  8. Lederman MM, Sprague L, Wallis RS, Ellner JJ: Duration of fever during treatment of infective endocarditis. Medicine 1992, 71:52–57.

    Article  PubMed  CAS  Google Scholar 

  9. Weinstein L: Life-threatening complications of infective endocarditis and their management. Arch Intern Med 1986, 146:953–957.

    Article  PubMed  CAS  Google Scholar 

  10. Greenberg DP, Bayer AS, Turner D, Ward JI: Antibody responses to protein A in patients with Staphylococcus aureus bacteremia and endocarditis. J Clin Microbiol 1990, 28:458–462.

    PubMed  CAS  Google Scholar 

  11. Coleman DL, Horwitz RI, Andriole VT: Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis. Am J Med 1982, 73:260–266.

    Article  PubMed  CAS  Google Scholar 

  12. Wilson WR, Karchmer AW, Dajani AS, et al.: Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995, 274:1706–1713. An excellent overview of the treatment of endocarditis.

    Article  PubMed  CAS  Google Scholar 

  13. Francioli P, Etienne J, Hoigné R, et al.: Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for four weeks: efficacy and outpatient treatment feasibility. JAMA 1992, 267:264–267.

    Article  PubMed  CAS  Google Scholar 

  14. Francioli P, Ruch W, Stamboulian D: Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis 1995, 21:1406–1410.

    PubMed  CAS  Google Scholar 

  15. Sexton DJ, Tenenbaum MJ, Wilson WR, et al.: Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Clin Infect Dis 1998, 27:1470–1474.

    PubMed  CAS  Google Scholar 

  16. Small PM, Chambers HF: Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990, 34:1227–1231. A landmark article establishing that vancomycin does not work as well as beta-lactam antibiotics in treating methicillinsusceptible Staphylococcus aureus infective endocarditis.

    PubMed  CAS  Google Scholar 

  17. DiNubile MJ: Short-course antibiotic therapy for rightsided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 1994, 121:873–876.

    PubMed  CAS  Google Scholar 

  18. Chambers HF, Miller RT, Newman MD: Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988, 109:619–624.

    PubMed  CAS  Google Scholar 

  19. Moon MR, Stinson EB, Miller DC: Surgical treatment of endocarditis. Prog Cardiovasc Dis 1997, 40:239–264.

    Article  PubMed  CAS  Google Scholar 

  20. DiNubile MJ: Surgery in active endocarditis. Ann Intern Med 1982, 96:650–699.

    PubMed  CAS  Google Scholar 

  21. Alsip SG, Blackstone EH, Kirklin JW, Cobbs CG: Indications of cardiac surgery in patients with active infective endocarditis. Am J Med 1985, 78:138–148.

    Article  PubMed  CAS  Google Scholar 

  22. Bauernschmitt R, Jakob HG, Vahl C-F, et al.: Operation for infective endocarditis: results after implantation of mechanical valves. Ann Thorac Surg 1998, 65:359–364. An excellent article demonstrating that surgery during active endocarditis can be life saving and is relatively safe.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Infectious Diseases, Rush-Presbyterian-St. Luke’s Medical Center, 600 S. Paulina St., 60612, Chicago, IL, USA

    John Segreti MD & Gordon M. Trenholme MD

Authors
  1. John Segreti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gordon M. Trenholme MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Segreti, J., Trenholme, G.M. Infective endocarditis. Curr Treat Options Cardio Med 1, 283–290 (1999). https://doi.org/10.1007/s11936-999-0045-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-999-0045-1

Keywords

Search

Navigation